[1] |
张欣欣,杨永忠,张艳玲,等. 药物洗脱支架联合药物涂层球囊处理冠状动脉分叉病变的研究[J]. 现代中西医结合杂志,2021, 30(32): 3570-3575.
|
[2] |
王振胜,李才元,包全儒. 血流储备分数评估老年冠心病患者介入治疗后分叉病变血管功能的研究[J]. 心肺血管病杂志,2021, 40(5): 426-429.
|
[3] |
乔勇,鄢高亮,王栋,等. 分支血管球囊预埋治疗老年冠状动脉分叉病变患者的疗效和安全性[J]. 中华老年医学杂志,2016, 35(2): 151-155.
|
[4] |
敖颖. 药物洗脱支架与药物涂层球囊治疗急性冠状动脉综合征患者的临床效果[J]. 医疗装备,2022, 35(16): 78-80.
|
[5] |
崔孔勇,尹栋,丰雷,等. 稳定性冠心病合并糖尿病患者药物洗脱支架置入术后延长双联抗血小板治疗的获益与风险[J]. 中华心血管病杂志,2022, 50(5): 458-465.
|
[6] |
陈韵岱,王建安,刘斌,等. 药物涂层球囊临床应用中国专家共识[J]. 中国介入心脏病学杂志,2016, 24(2): 61-67.
|
[7] |
Burzotta F, Lassen JF, Lefèvre T, et al. Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European bifurcation club[J]. EuroIntervention, 2021, 16(16): 1307-1317.
|
[8] |
Kulyassa P, Engh MA, Vámosi P, et al. Drug-coated balloon therapy is more effective in treating late drug-eluting stent in-stent restenosis than the early occurring one-a systematic review and meta-analysis[J]. Front Cardiovasc Med, 2023, 10: 106-130.
|
[9] |
Buono A, Maffeo D, Pellicano M, et al. Back to the future: the role of DCB for the treatment of coronary bifurcation[J]. Rev Cardiovasc Med, 2021, 22(4): 1421-1428.
|
[10] |
Zilio F, Verdoia M, De Angelis MC, et al. Drug coated balloon in the treatment of de novo coronary artery disease: a narrative review[J]. J Clin Med, 2023, 12(11): 3662.
|
[11] |
Muramatsu T, Kozuma K, Tanabe K, et al. Clinical expert consensus document on drug-coated balloon for coronary artery disease from the Japanese association of cardiovascular intervention and therapeutics[J]. Cardiovasc Interv Ther, 2023, 38(2): 166-176.
|
[12] |
Jiang ZM, Liu L. Drug-coated versus uncoated balloon for side branch protection in coronary bifurcation lesions treated with provisional stenting using drug-eluting stents: a meta-analysis[J]. Int J Clin Pract, 2022, 2022: 5892589.
|
[13] |
Corballis NH, Paddock S, Gunawardena T, et al. Drug coated balloons for coronary artery bifurcation lesions: a systematic review and focused meta-analysis[J]. PLoS One, 2021, 16(7): e0251986.
|
[14] |
Ikuta A, Kubo S, Ohya M, et al. Impact of late lumen loss on clinical outcomes of side-branch bifurcation lesions treated by drug-coated balloon angioplasty with main-branch stenting[J]. Cardiovasc Revasc Med, 2022, 41: 92-98.
|
[15] |
Berland J, Lefèvre T, Brenot P, et al. Danubio-a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial[J]. EuroIntervention, 2015, 11(8): 868-876.
|
[16] |
Pellegrini D, Donahue M, Regazzoli D, et al. Drug-coated balloon combined with drug-eluting stent for the treatment of coronary bifurcation lesions: insights from the HYPER study[J]. Eur Heart J Suppl, 2023, 25(Suppl C): C79-C83.
|
[17] |
Kitani S, Igarashi Y, Tsuchikane E, et al. Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry)[J]. Catheter Cardiovasc Interv, 2021, 97(5): E614-E623.
|
[18] |
Jim MH, Lee MK, Fung RC, et al. Six month angiographic result of supplementary paclitaxel-eluting balloon deployment to treat side branch ostium narrowing (SARPEDON)[J]. Int J Cardiol, 2015, 187: 594-597.
|